Cigna Investments’s Health Catalyst HCAT Stock Holding History

Cigna Investments’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$27K	Sell	13,518 -481	-3%	-$694	﹤0.01%	480
2026 Q1	$18K	Hold	13,999	–	–	﹤0.01%	455
2025 Q4	$33K	Hold	13,999	–	–	﹤0.01%	459
2025 Q3	$40K	Hold	13,999	–	–	0.01%	469
2025 Q2	$53K	Hold	13,999	–	–	0.01%	451
2025 Q1	$63K	Hold	13,999	–	–	0.01%	440
2024 Q4	$99K	Hold	13,999	–	–	0.02%	454
2024 Q3	$114K	Hold	13,999	–	–	0.02%	462
2024 Q2	$89K	Sell	13,999 -80	-0.6%	-$514	0.02%	441
2024 Q1	$107K	Hold	14,079	–	–	0.02%	455
2023 Q4	$130K	Hold	14,079	–	–	0.03%	434
2023 Q3	$143K	Hold	14,079	–	–	0.03%	410
2023 Q2	$176K	Hold	14,079	–	–	0.03%	444
2023 Q1	$165K	Hold	14,079	–	–	0.03%	440
2022 Q4	$150K	Hold	14,079	–	–	0.03%	440
2022 Q3	$137K	Hold	14,079	–	–	0.03%	420
2022 Q2	$204K	Hold	14,079	–	–	0.04%	436
2022 Q1	$368K	Buy	14,079 +239	+2%	+$6.78K	0.05%	388
2021 Q4	$549K	Hold	13,840	–	–	0.04%	346
2021 Q3	$692K	Hold	13,840	–	–	0.05%	332
2021 Q2	$767K	Buy	13,840 +133	+1%	+$7.08K	0.05%	313
2021 Q1	$641K	Buy	+13,707	New	+$664K	0.04%	381

Other funds holding HCAT

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

CDC Financial Chicago, Illinois $239M AUM

PVM

Palogic Value Management Dallas, Texas $306M AUM 15.41% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $317M AUM 37.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cigna Investments's HCAT Position: Q2 2026 in Review

Cigna Investments reduced its Health Catalyst (HCAT) stake by 3.4% in Q2 2026, selling an estimated $694 and leaving 13,518 shares worth $27K. The position accounts for ﹤0.01% of the portfolio, ranked #480.

Cigna Investments first reported a position in HCAT in Q1 2021 and has held it in 22 quarters since. The position peaked at $767K in Q2 2021. 126 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

Cigna Investments held 13,518 shares of Health Catalyst worth $27K as of Q2 2026.
Cigna Investments sold 481 Health Catalyst shares in Q2 2026, an estimated $694.
Health Catalyst made up ﹤0.01% of Cigna Investments's portfolio in Q2 2026, its #480 holding.
Cigna Investments first reported a position in Health Catalyst in Q1 2021 and has held it in 22 quarters since.
Cigna Investments's Health Catalyst position peaked at $767K in Q2 2021.
126 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Cigna Investments's 13F filing for Q2 2026, filed 21 Jul 2026.